{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:38:42Z","timestamp":1793119122977,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to explore the relationship between insulin resistance (IR) and adverse pregnancy outcomes in women with gestational diabetes mellitus (GDM), and to determine the risk factors for IR in women with GDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study employed a retrospective survey of 710 women diagnosed with GDM. Serum lipids, fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c), and serum protein were measured in the first trimester (6\u201312\u00a0weeks), and OGTT and fasting insulin tests were performed in the second trimester (24\u201328\u00a0weeks). These results were then used to evaluate IR by homeostasis model assessment (HOMA). When HOMA-IR\u2009\u2265\u20092.0, IR was diagnosed. The relationship between HOMA-IR and adverse pregnancy outcomes was analyzed by a logistic regression model, and multiple stepwise regression was used to analyze the risk factors of IR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IR significantly increasd the risk of the hypertensive disorders of pregnancy and large for gestational age (LGA) (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20095.31,\n                      <jats:italic>95%CI<\/jats:italic>\n                      :1.87,15.10;\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20091.65,\n                      <jats:italic>95%CI<\/jats:italic>\n                      :1.10, 2.48, respectively) in women with GDM, but not for cesarean section, premature delivery, premature rupture of membranes, postpartum hemorrhage, macrosomia and SGA. Compared to normal groups, greater body mass index (BMI) before pregnancy category (overweight or obesity group) were associated with higher risk of IR in the second trimester, the\n                      <jats:italic>OR (95% CI)<\/jats:italic>\n                      were 4.09 (2.65, 6.30) and 6.52 (2.99, 14.20). And higher level of FPG (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20091.63,\n                      <jats:italic>95%CI:<\/jats:italic>\n                      1.11, 2.40), TG (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20091.32,\n                      <jats:italic>95%CI:<\/jats:italic>\n                      1.08, 1.63) and weight gain before diagnosis of GDM (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20091.08,\n                      <jats:italic>95%CI:<\/jats:italic>\n                      1.02, 1.15) were also associated with higher risk of IR in the second trimester in women with GDM, while age (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20090.94,\n                      <jats:italic>95%CI<\/jats:italic>\n                      : 0.90, 0.98)was the weak protective factor for IR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GDM with IR in the second trimester increased adverse pregnancy outcomes, especially the risk of hypertensive disorders of pregnancy and LGA. In addition, FPG, HbA1c, and TG in early pregnancy, pre-pregnant BMI and weight gain before diagnosis of GDM were all independent risk factors for IR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-021-04006-x","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T09:03:00Z","timestamp":1627030980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Associations between insulin resistance and adverse pregnancy outcomes in women with gestational diabetes mellitus: a retrospective study"],"prefix":"10.1186","volume":"21","author":[{"given":"Jing","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"4006_CR1","doi-asserted-by":"publisher","first-page":"107841","DOI":"10.1016\/j.diabres.2019.107841","volume":"157","author":"L Yuen","year":"2019","unstructured":"Yuen L, et al. Projections of the prevalence of hyperglycaemia in pregnancy in 2019 and beyond: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107841.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"4006_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/jdi.12854","volume":"10","author":"C Gao","year":"2019","unstructured":"Gao C, et al. Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta-analysis. J Diabetes Investig. 2019;10(1):154\u201362.","journal-title":"J Diabetes Investig"},{"issue":"3","key":"4006_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/dme.12381","volume":"31","author":"PM Catalano","year":"2014","unstructured":"Catalano PM. Trying to understand gestational diabetes. Diabet Med. 2014;31(3):273\u201381.","journal-title":"Diabet Med"},{"issue":"4","key":"4006_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.semperi.2015.05.002","volume":"39","author":"C Durnwald","year":"2015","unstructured":"Durnwald C. Gestational diabetes: Linking epidemiology, excessive gestational weight gain, adverse pregnancy outcomes, and future metabolic syndrome. Semin Perinatol. 2015;39(4):254\u20138.","journal-title":"Semin Perinatol"},{"issue":"4","key":"4006_CR5","first-page":"801","volume":"71","author":"KV Tarasenko","year":"2018","unstructured":"Tarasenko KV, et al. Pathogenesis of insulin resistance in pregnant women with obesity. Wiad Lek. 2018;71(4):801\u20136.","journal-title":"Wiad Lek"},{"issue":"2","key":"4006_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3109\/14767050903156650","volume":"23","author":"A Levy","year":"2010","unstructured":"Levy A, et al. Family history of diabetes mellitus as an independent risk factor for macrosomia and cesarean delivery. J Matern Fetal Neonatal Med. 2010;23(2):148\u201352.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4006_CR7","doi-asserted-by":"publisher","unstructured":"Di Marzo V, Silvestri C. Lifestyle and metabolic syndrome: contribution of the endocannabinoidome. Nutrients. 2019;11(8):1956.\u00a0https:\/\/doi.org\/10.3390\/nu11081956.","DOI":"10.3390\/nu11081956"},{"issue":"9677","key":"4006_CR8","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","volume":"373","author":"L Bellamy","year":"2009","unstructured":"Bellamy L, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773\u20139.","journal-title":"Lancet"},{"issue":"11","key":"4006_CR9","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00125-018-4688-x","volume":"61","author":"A Pitchika","year":"2018","unstructured":"Pitchika A, et al. Associations of maternal type 1 diabetes with childhood adiposity and metabolic health in the offspring: a prospective cohort study. Diabetologia. 2018;61(11):2319\u201332.","journal-title":"Diabetologia"},{"issue":"1 Pt 1","key":"4006_CR10","first-page":"E60","volume":"264","author":"PM Catalano","year":"1993","unstructured":"Catalano PM, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993;264(1 Pt 1):E60\u20137.","journal-title":"Am J Physiol"},{"issue":"6","key":"4006_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/1753-0407.13013","volume":"12","author":"YY Sun","year":"2020","unstructured":"Sun YY, et al. Increasing insulin resistance predicts adverse pregnancy outcomes in women with gestational diabetes mellitus. J Diabetes. 2020;12(6):438\u201346.","journal-title":"J Diabetes"},{"issue":"11","key":"4006_CR12","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1007\/s00125-019-4961-7","volume":"62","author":"K Benhalima","year":"2019","unstructured":"Benhalima K, et al. Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance. Diabetologia. 2019;62(11):2118\u201328.","journal-title":"Diabetologia"},{"issue":"4","key":"4006_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s11892-009-0046-1","volume":"9","author":"DS Mastrogiannis","year":"2009","unstructured":"Mastrogiannis DS, et al. Insulin resistance: the possible link between gestational diabetes mellitus and hypertensive disorders of pregnancy. Curr Diab Rep. 2009;9(4):296\u2013302.","journal-title":"Curr Diab Rep"},{"issue":"3","key":"4006_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/14767058.2012.715006","volume":"26","author":"S Longo","year":"2013","unstructured":"Longo S, et al. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med. 2013;26(3):222\u20135.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"4006_CR15","first-page":"Cd012394","volume":"6","author":"RJ Griffith","year":"2020","unstructured":"Griffith RJ, et al. Interventions to prevent women from developing gestational diabetes mellitus: an overview of cochrane reviews. Cochrane Database Syst Rev. 2020;6(6):Cd012394.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"4006_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/dmt.10.24","volume":"1","author":"S Ernst","year":"2011","unstructured":"Ernst S, et al. Mechanisms in the adaptation of maternal \u03b2-cells during pregnancy. Diabetes Manag (Lond). 2011;1(2):239\u201348.","journal-title":"Diabetes Manag (Lond)"},{"issue":"6","key":"4006_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.24953\/turkjped.2017.06.002","volume":"59","author":"A Naseh","year":"2017","unstructured":"Naseh A, et al. Associations between anthropometric characteristics and insulin markers in mothers and their neonates and with neonate`s birth weight: An observational cohort study. Turk J Pediatr. 2017;59(6):625\u201335.","journal-title":"Turk J Pediatr"},{"issue":"9","key":"4006_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s40618-016-0607-5","volume":"40","author":"E Chiefari","year":"2017","unstructured":"Chiefari E, et al. Gestational diabetes mellitus: an updated overview. J Endocrinol Invest. 2017;40(9):899\u2013909.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"4006_CR19","first-page":"97","volume":"53","author":"L Zhu","year":"2015","unstructured":"Zhu L, et al. Chinese neonatal birth weight curve for different gestational age. Zhonghua Er Ke Za Zhi. 2015;53(2):97\u2013103.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"4006_CR20","first-page":"1","volume":"17 Suppl","author":"C Chen","year":"2004","unstructured":"Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17 Suppl:1\u201336.","journal-title":"Biomed Environ Sci"},{"key":"4006_CR21","doi-asserted-by":"publisher","unstructured":"Zhang CX, et al. Optimal gestational weight gain in Chinese pregnant women by Chinese-specific body mass index categories: a multicenter prospective cohort study. Public Health Nutr. 2021:1\u201311.\u00a0https:\/\/doi.org\/10.1017\/S1368980021001622.","DOI":"10.1017\/S1368980021001622"},{"issue":"9","key":"4006_CR22","doi-asserted-by":"publisher","first-page":"e0163424","DOI":"10.1371\/journal.pone.0163424","volume":"11","author":"CH Lee","year":"2016","unstructured":"Lee CH, et al. Optimal Cut-Offs of Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) to Identify dysglycemia and type 2 diabetes mellitus: a 15-year prospective study in Chinese. PLoS One. 2016;11(9):e0163424.","journal-title":"PLoS One"},{"key":"4006_CR23","doi-asserted-by":"publisher","first-page":"140851","DOI":"10.1155\/2014\/140851","volume":"2014","author":"FR Abhari","year":"2014","unstructured":"Abhari FR, et al. Estimating rate of insulin resistance in patients with preeclampsia using HOMA-IR index and comparison with nonpreeclampsia pregnant women. Biomed Res Int. 2014;2014:140851.","journal-title":"Biomed Res Int"},{"key":"4006_CR24","doi-asserted-by":"publisher","first-page":"5947859","DOI":"10.1155\/2017\/5947859","volume":"2017","author":"R Villalobos-Labra","year":"2017","unstructured":"Villalobos-Labra R, et al. Akt\/mTOR role in human foetoplacental vascular insulin resistance in diseases of pregnancy. J Diabetes Res. 2017;2017:5947859.","journal-title":"J Diabetes Res"},{"issue":"4","key":"4006_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/MAJ.0b013e3180a6f094","volume":"334","author":"RE Harskamp","year":"2007","unstructured":"Harskamp RE, Zeeman GG. Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci. 2007;334(4):291\u20135.","journal-title":"Am J Med Sci"},{"key":"4006_CR26","doi-asserted-by":"publisher","unstructured":"Ellett T, et al. Pregnancy outcomes among women with class III obesity with normal early glucola. J Matern Fetal Neonatal Med. 2021:1\u20136.\u00a0https:\/\/doi.org\/10.1080\/14767058.2021.1895741.","DOI":"10.1080\/14767058.2021.1895741"},{"key":"4006_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000371628","volume":"66 Suppl 2","author":"K Kc","year":"2015","unstructured":"Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66 Suppl 2:14\u201320.","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"4006_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1080\/14767058.2019.1609929","volume":"34","author":"J Yan","year":"2021","unstructured":"Yan J, et al. Epigenetic alteration of Rho guanine nucleotide exchange factor 11 (ARHGEF11) in cord blood samples in macrosomia exposed to intrauterine hyperglycemia. J Matern Fetal Neonatal Med. 2021;34(3):422\u201331.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"4006_CR29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/jmwh.12927","volume":"64","author":"M McDowell","year":"2019","unstructured":"McDowell M, Cain MA, Brumley J. Excessive gestational weight gain. J Midwifery Womens Health. 2019;64(1):46\u201354.","journal-title":"J Midwifery Womens Health"},{"issue":"6","key":"4006_CR30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.dsx.2018.06.019","volume":"12","author":"AP Sunjaya","year":"2018","unstructured":"Sunjaya AP, Sunjaya AF. Diabetes in pregnancy and infant mortality: link with glycemic control. Diabetes Metab Syndr. 2018;12(6):1031\u20137.","journal-title":"Diabetes Metab Syndr"},{"issue":"10","key":"4006_CR31","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1172\/JCI129188","volume":"129","author":"LI Hudish","year":"2019","unstructured":"Hudish LI, Reusch JE, Sussel L. \u03b2 Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Invest. 2019;129(10):4001\u20138.","journal-title":"J Clin Invest"},{"key":"4006_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1472-6823-13-21","volume":"13","author":"A Sokup","year":"2013","unstructured":"Sokup A, et al. Insulin resistance as estimated by the homeostatic method at diagnosis of gestational diabetes: estimation of disease severity and therapeutic needs in a population-based study. BMC Endocr Disord. 2013;13:21.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"4006_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1056-8727(03)00030-8","volume":"18","author":"X Yang","year":"2004","unstructured":"Yang X, et al. The effect of glucose levels on fetal birth weight: a study of Chinese gravidas in Tianjin China. J Diabetes Complications. 2004;18(1):37\u201341.","journal-title":"J Diabetes Complications"},{"key":"4006_CR34","doi-asserted-by":"publisher","unstructured":"Li J, et al. Roles of insulin resistance and beta cell dysfunction in macrosomia among Chinese women with gestational diabetes mellitus. Prim Care Diabetes. 2018;12(6):565\u201373. https:\/\/doi.org\/10.1016\/j.pcd.2018.07.010.","DOI":"10.1016\/j.pcd.2018.07.010"},{"key":"4006_CR35","doi-asserted-by":"publisher","unstructured":"Barnes R, et al. Excessive weight gain before and during gestational diabetes mellitus management: what is the impact? Diabetes Care. 2020;43(1):74\u201381.\u00a0https:\/\/doi.org\/10.2337\/dc19-0800","DOI":"10.2337\/dc19-0800"},{"key":"4006_CR36","doi-asserted-by":"publisher","unstructured":"Saeedi M, et al. Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG criteria: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2021;172:108642.\u00a0https:\/\/doi.org\/10.1016\/j.diabres.2020.108642","DOI":"10.1016\/j.diabres.2020.108642"},{"key":"4006_CR37","doi-asserted-by":"publisher","unstructured":"Plows JF, et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19(11):3342.\u00a0https:\/\/doi.org\/10.3390\/ijms19113342.","DOI":"10.3390\/ijms19113342"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04006-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04006-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04006-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T06:25:19Z","timestamp":1699251919000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04006-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4006"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04006-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-235578\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"assertion":[{"value":"12 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board Project # No. HZKY-PJ-2020\u201342 was approved on 12 May 2020 by the Sixth Medical Center of PLA General Hospital Ethics Committee. All study participants gave verbal informed consent, this was approved by the Sixth Medical Center of PLA General Hospital Ethics Committee as it was a retrospective study and no interventions was given to the participants. This manuscript reported adherence to Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"526"}}